Chemotherapy Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ASCO GU 2016 Role of neoadjuvant chemotherapy and the impact of the latest randomized trials in bladder cancer
Matthew Galsky, MD Director of Genitourinary Medical Oncology at the Tisch Cancer Institute discusses the role of neoadjuvant chemotherapy and the impact of the latest randomized trials in bladder can... Author: 2016_Genitourinary Added: 01/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2016 Category: Cancer & Oncology Source Type: podcasts

Managing Immunotherapy Side Effects
Dr. Evan J. Lipson, Johns Hopkins University, discusses the incidence and treatment of side effects of immunotherapy and compares them to chemotherapy toxicities. http://cancergrace.org/canc...... Author: cancergrace Added: 01/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2016 Category: Cancer & Oncology Source Type: podcasts

ASCO GU 2016 Immune checkpoint inhibitors in combination with chemotherapy or targeted agents for urothelial cancers
Matthew Galsky, MD Director of Genitourinary Medical Oncology at the Tisch Cancer Institute discusses Immune checkpoint inhibitors in combination with chemotherapy or targeted agents for urothelial ca... Author: 2016_Genitourinary Added: 01/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2016 Category: Cancer & Oncology Source Type: podcasts

ASCO GU 2016 Adjuvant radiation v. chemo-RT v. chemotherapy alone after radical cystectomy for locally advanced bladder cancer
Matthew Galsky, MD Director of Genitourinary Medical Oncology at the Tisch Cancer Institute discusses Adjuvant radiation v. chemo-RT v. chemotherapy alone after radical cystectomy for locally advanced... Author: 2016_Genitourinary Added: 01/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2016 Category: Cancer & Oncology Source Type: podcasts

Ibrutinib vs chlorambucil in CLL patients not suitable for chemotherapy
Thomas J Kipps, MD from the University of California, San Diego, CA, provides an overview of the clinical trial RESONATE-2 comparing ibrutinib with chlorambucil in chronic lymphocytic leukemia (CLL) p... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts